发明公开
- 专利标题： COMPOUNDS AS COR5 ANTAGONISTS
- 专利标题（中）： VERBINDUNGEN ALS COR5-ANTAGONISTEN
-
申请号： EP05745210.4申请日： 2005-05-12
-
公开(公告)号： EP1760079A1公开(公告)日： 2007-03-07
- 发明人: PEI, Gang , MA, Dawei , CHEN, Li , YU, Shanghai , LI, Ben , DONG, Fang , LV, Yanhui , CHEN, Renhai , ZHANG, Jin
- 申请人： Shanghai Target Drug Co., Ltd.
- 申请人地址： 500 Caobao Road Shanghai 200233 CN
- 专利权人： Shanghai Target Drug Co., Ltd.
- 当前专利权人： Shanghai Target Drug Co., Ltd.
- 当前专利权人地址： 500 Caobao Road Shanghai 200233 CN
- 代理机构： Esteban Perez-Serrano, Maria Isabel
- 优先权： CN200410025006 20040609
- 国际公布： WO2005121123 20051222
- 主分类号： C07D401/06
- IPC分类号： C07D401/06 ; C07D403/08 ; C07D413/08 ; A61K31/4025 ; A61K31/435 ; A61P31/18 ; A61P1/00 ; A61P17/00 ; A61P19/00
摘要：
The present invention discloses the compounds of formula I or their pharmaceutically acceptable salts, which are useful as CCR5 antagonists. The preparation and use of the compounds of formula I, pharmaceutical composition containing the same are also disclosed. Furthermore, the present invention discloses an intermediate for the preparation of the compounds of formula I.
信息查询
